Mohammadi-Meyabadi, R.; Mallandrich, M.; Beirampour, N.; Garrós, N.; Espinoza, L.C.; Sosa, L.; Suñer-Carbó, J.; RodrÃguez-Lagunas, M.J.; Garduño-RamÃrez, M.L.; Calpena-Campmany, A.C.
Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis. Pharmaceutics 2024, 16, 1287.
https://doi.org/10.3390/pharmaceutics16101287
AMA Style
Mohammadi-Meyabadi R, Mallandrich M, Beirampour N, Garrós N, Espinoza LC, Sosa L, Suñer-Carbó J, RodrÃguez-Lagunas MJ, Garduño-RamÃrez ML, Calpena-Campmany AC.
Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis. Pharmaceutics. 2024; 16(10):1287.
https://doi.org/10.3390/pharmaceutics16101287
Chicago/Turabian Style
Mohammadi-Meyabadi, Roya, Mireia Mallandrich, Negar Beirampour, Núria Garrós, Lupe Carolina Espinoza, Lilian Sosa, Joaquim Suñer-Carbó, MarÃa José RodrÃguez-Lagunas, MarÃa Luisa Garduño-RamÃrez, and Ana C. Calpena-Campmany.
2024. "Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis" Pharmaceutics 16, no. 10: 1287.
https://doi.org/10.3390/pharmaceutics16101287
APA Style
Mohammadi-Meyabadi, R., Mallandrich, M., Beirampour, N., Garrós, N., Espinoza, L. C., Sosa, L., Suñer-Carbó, J., RodrÃguez-Lagunas, M. J., Garduño-RamÃrez, M. L., & Calpena-Campmany, A. C.
(2024). Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis. Pharmaceutics, 16(10), 1287.
https://doi.org/10.3390/pharmaceutics16101287
